Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Biophysical Markers of Suspected Preeclampsia, Fetal Growth Restriction and The Two Combined—How Accurate They Are?

View through CrossRef
Objectives—To conduct a secondary analysis of prediction accuracy of biophysical markers for suspected Preeclampsia (PE), Fetal Growth Restriction (FGR) and the two combined near delivery in a Slovenian cohort. Methods—This was a secondary analysis of a database of a total 125 Slovenian pregnant women attending a high-risk pregnancy clinic due to suspected PE (n = 31), FGR (n = 16) and PE + FGR (n = 42) from 28–39 weeks gestation and their corresponding term (n = 21) and preterm (PTD, n = 15) controls. Data for Mean Arterial blood Pressure (MAP) and Uterine artery pulsatility index (UtA PI) estimated by Doppler sonography were extracted from the database of patients who were tested at admission to the high-risk clinic with the suspected complications. The reactive hyperemia index (RHI), and the Augmentation Index (AIX%) were extracted from the patient database using measured values obtained with the assistance of the Endo PAT, a device set to measure the signal of the peripheral arterial tone (PAT) from the blood vessels endothelium. Linear regression coefficients, Box and Whisker plots, Area under the Curve (AUC) of receiver Operation Characteristic (ROC) curves, and multiple regression were used to assess the marker accuracy using detection rate (DR) and false-positive rate (FPR) and previously reported cut-offs for estimating the positive and negative predictive value (NPV and PPV). The SPSS non-parametric statistics (Kruskal Wallis and Mann–Whitney) and Spearman’s regression coefficient were used to assess marker accuracy; p < 0.05 was considered significant. Results—MAP values reached diagnostic accuracy (AUC = 1.00, DR = 100%) for early PE cases delivered < 34, whereas UtA Doppler PI values yielded such results for early FGR < 34 weeks and the two combined reached such accuracy for PE + FGR. To reach diagnostic accuracy for all cases of the complications, the Endo PAT markers with values for MAP and UtA Doppler PI were required for cases near delivery. Multiple regression analyses showed added value for advanced maternal age and gestational week in risk assessment for all cases of PE, FGR, and PE + FGR. Spearman’s regression coefficient yielded r > 0.6 for UtA Doppler PI over GA for PE and FGR, whereas for RHI over BMI, the regression coefficient was r > 0.5 (p < 0.001 for each). Very high correlations were also found between UtA Doppler PI and sFlt-1/PlGF or PlGF (r = −0.495, p < 0.001), especially in cases of FGR. Conclusion—The classical biophysical markers MAP and UtA Doppler PI provided diagnostic accuracy for PE and FGR < 34 wks gestation. A multiple biophysical marker analysis was required to reach diagnostic accuracy for all cases of these complications. The UtA Doppler PI and maternal serum sFlt-1/PlGF or PlGF were equally accurate for early cases to enable the choice of the markers for the clinical use according to the more accessible method.
Title: Biophysical Markers of Suspected Preeclampsia, Fetal Growth Restriction and The Two Combined—How Accurate They Are?
Description:
Objectives—To conduct a secondary analysis of prediction accuracy of biophysical markers for suspected Preeclampsia (PE), Fetal Growth Restriction (FGR) and the two combined near delivery in a Slovenian cohort.
Methods—This was a secondary analysis of a database of a total 125 Slovenian pregnant women attending a high-risk pregnancy clinic due to suspected PE (n = 31), FGR (n = 16) and PE + FGR (n = 42) from 28–39 weeks gestation and their corresponding term (n = 21) and preterm (PTD, n = 15) controls.
Data for Mean Arterial blood Pressure (MAP) and Uterine artery pulsatility index (UtA PI) estimated by Doppler sonography were extracted from the database of patients who were tested at admission to the high-risk clinic with the suspected complications.
The reactive hyperemia index (RHI), and the Augmentation Index (AIX%) were extracted from the patient database using measured values obtained with the assistance of the Endo PAT, a device set to measure the signal of the peripheral arterial tone (PAT) from the blood vessels endothelium.
Linear regression coefficients, Box and Whisker plots, Area under the Curve (AUC) of receiver Operation Characteristic (ROC) curves, and multiple regression were used to assess the marker accuracy using detection rate (DR) and false-positive rate (FPR) and previously reported cut-offs for estimating the positive and negative predictive value (NPV and PPV).
The SPSS non-parametric statistics (Kruskal Wallis and Mann–Whitney) and Spearman’s regression coefficient were used to assess marker accuracy; p < 0.
05 was considered significant.
Results—MAP values reached diagnostic accuracy (AUC = 1.
00, DR = 100%) for early PE cases delivered < 34, whereas UtA Doppler PI values yielded such results for early FGR < 34 weeks and the two combined reached such accuracy for PE + FGR.
To reach diagnostic accuracy for all cases of the complications, the Endo PAT markers with values for MAP and UtA Doppler PI were required for cases near delivery.
Multiple regression analyses showed added value for advanced maternal age and gestational week in risk assessment for all cases of PE, FGR, and PE + FGR.
Spearman’s regression coefficient yielded r > 0.
6 for UtA Doppler PI over GA for PE and FGR, whereas for RHI over BMI, the regression coefficient was r > 0.
5 (p < 0.
001 for each).
Very high correlations were also found between UtA Doppler PI and sFlt-1/PlGF or PlGF (r = −0.
495, p < 0.
001), especially in cases of FGR.
Conclusion—The classical biophysical markers MAP and UtA Doppler PI provided diagnostic accuracy for PE and FGR < 34 wks gestation.
A multiple biophysical marker analysis was required to reach diagnostic accuracy for all cases of these complications.
The UtA Doppler PI and maternal serum sFlt-1/PlGF or PlGF were equally accurate for early cases to enable the choice of the markers for the clinical use according to the more accessible method.

Related Results

Identification of a rational, physiologically based early biomarker and pathogenic pathway For preeclampsia
Identification of a rational, physiologically based early biomarker and pathogenic pathway For preeclampsia
<p>Preeclampsia is a hypertensive disorder of pregnancy that is diagnosed after the 20th week of gestation. It is defined by the American College of Obstetrics and Gynecology...
Complicaciones asociadas a la preeclampsia en pacientes atendidas en el Hospital de Supe – Lima – 2021
Complicaciones asociadas a la preeclampsia en pacientes atendidas en el Hospital de Supe – Lima – 2021
Objetivo: Determinar las complicaciones asociadas a la preeclampsia en pacientes atendidas en el Hospital de Supe – Lima - 2021 Metodología: Estudio de tipo Observacional, trasvers...
First Trimester Uterine Artery Doppler Screening for Preeclampsia
First Trimester Uterine Artery Doppler Screening for Preeclampsia
Background: Several screening strategies have been proposed to identify patients in early pregnancy at increased risk of preeclampsia who may benefit from low dose aspirin (LDA) to...
Serum catestatin level in preeclampsia
Serum catestatin level in preeclampsia
Background/Aim: Preeclampsia, a significant cause of maternal morbidity and mortality, is linked to increased cardiovascular risks. Catestatin regulates cardiovascular function whi...
Penyuluhan dan Deteksi Dini Preeklamsia pada Ibu Hamil Berdasarkan Karakteristik di Rumah Sakit Setio Husodo
Penyuluhan dan Deteksi Dini Preeklamsia pada Ibu Hamil Berdasarkan Karakteristik di Rumah Sakit Setio Husodo
Preeclampsia plays a role in intrauterine death and perinatal mortality. Preeclampsia is a risk factor for slow fetal growth, low birth weight (LBW), fetal dysmaturity and prematur...
Correlation of Neutrophil Lymphocyte Ration (NLR) Values with Severe Preeclampsia, HELLP Syndrome and Eclampsia
Correlation of Neutrophil Lymphocyte Ration (NLR) Values with Severe Preeclampsia, HELLP Syndrome and Eclampsia
Background:  Preeclampsia (PE) is the leading cause of maternal and fetal morbidity and mortality. The disease is characterized by hypertension (≥140/90 mmHg), proteinuria, thro...
Differences in Hematocrit and Leukocyte Levels in Preeclampsia and Severe Preeclampsia
Differences in Hematocrit and Leukocyte Levels in Preeclampsia and Severe Preeclampsia
Introduction:  Preeclampsia is a serious pregnancy complication characterized by hypertension occurring at a gestational age of ≥ 20 weeks. In preeclampsia, hematological changes o...
Hemostasis Alterations and Placental Outcomes in Preeclampsia
Hemostasis Alterations and Placental Outcomes in Preeclampsia
General Background: Pregnancy induces profound physiological changes in the hemostasis system, balancing procoagulant and fibrinolytic mechanisms to ensure maternal and fetal survi...

Back to Top